KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) EBT: 2014-2024

Historic EBT for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to -$533.0 million.

  • BeOne Medicines' EBT rose 249.70% to $147.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $182.3 million, marking a year-over-year increase of 122.83%. This contributed to the annual value of -$533.0 million for FY2024, which is 35.46% up from last year.
  • Latest data reveals that BeOne Medicines reported EBT of -$533.0 million as of FY2024, which was up 35.46% from -$825.8 million recorded in FY2023.
  • Over the past 5 years, BeOne Medicines' EBT peaked at -$533.0 million during FY2024, and registered a low of -$2.0 billion during FY2022.
  • Moreover, its 3-year median value for EBT was -$825.8 million (2023), whereas its average is -$1.1 billion.
  • Per our database at Business Quant, BeOne Medicines' EBT plummeted by 71.49% in 2020 and then soared by 57.89% in 2023.
  • BeOne Medicines' EBT (Yearly) stood at -$1.6 billion in 2020, then grew by 9.91% to -$1.5 billion in 2021, then tumbled by 34.52% to -$2.0 billion in 2022, then soared by 57.89% to -$825.8 million in 2023, then surged by 35.46% to -$533.0 million in 2024.